Bone Densitometers Market: Lack of Access to Diagnostics
[117 Pages Report] The global bone densitometers market is projected to reach USD 311 million by
2024 from USD 247 million in 2019, at a CAGR of 4.7%.
The growth in the Peripheral Bone Densitometers Market is majorly driven by the increasing prevalence
of osteoporosis and the rising geriatric population. However, factors such as the high cost of bone
densitometers and low awareness are expected to hinder the growth of this market.
Download a PDF Brochure @
The osteoporosis & osteopenia diagnosis segment is expected to grow at the highest CAGR
On the basis of application, the Bone Densitometers Market has been segmented into osteoporosis &
osteopenia diagnosis, body composition measurement, rheumatoid arthritis diagnosis, cystic fibrosis
diagnosis, and chronic kidney disease diagnosis. The osteoporosis & osteopenia diagnosis segment is
projected to grow at the highest CAGR during the forecast period. This can be attributed to the growing
geriatric population and the subsequent increase in the prevalence of osteoporosis, the increasing risk
of osteoporosis in menopausal women, and the growing global incidence of fragility fractures.
Request a Sample Pages @
The hospitals & specialty clinics segment accounted for the largest share of the bone densitometers
market in 2018
Based on end user, the Peripheral Bone Densitometers Market is segmented into hospitals & specialty
clinics, diagnostic & imaging centers, and other end users. In 2018, hospitals & specialty clinics
accounted for the largest share of the market, and this trend is expected to continue during the forecast
period. The majority of bone density scans are performed in hospitals owing to the higher preference of
patients for hospital-based treatment monitoring for diseases such as cystic fibrosis, chronic kidney
diseases, and osteoporosis.